Fingerpaint Group announced the rebranding of its market access solution, formerly known as 1798, to Fingerpaint Market Access, a highly integrated end-to-end consultancy offering strategy development through creative execution.
Fingerpaint Market Access is built on a foundation of firsthand experience from seasoned experts who have been involved in more than 30 launches in just the past three years. With its very own design studio, Fingerpaint Market Access offers everything from tactical support to collateral material development.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.